Freestone Grove Partners’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.44M Sell
74,058
-1,393,635
-95% -$27.6M 0.01% 473
2026
Q1
$28.2M Sell
1,467,693
-372,942
-20% -$7.35M 0.2% 167
2025
Q4
$34.9M Buy
+1,840,635
New +$34.1M 0.25% 125

Other funds holding SBRA

Freestone Grove Partners's SBRA Position: Q2 2026 in Review

Freestone Grove Partners reduced its Sabra Healthcare REIT (SBRA) stake by 95% in Q2 2026, selling an estimated $27.6M and leaving 74,058 shares worth $1.44M. The position accounts for 0.01% of the portfolio, ranked #473.

Freestone Grove Partners first reported a position in SBRA in Q4 2025 and has held it in 3 quarters since. The position peaked at $34.9M in Q4 2025. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Freestone Grove Partners held 74,058 shares of Sabra Healthcare REIT worth $1.44M as of Q2 2026.
  • Freestone Grove Partners sold 1,393,635 Sabra Healthcare REIT shares in Q2 2026, an estimated $27.6M.
  • Sabra Healthcare REIT made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #473 holding.
  • Freestone Grove Partners first reported a position in Sabra Healthcare REIT in Q4 2025 and has held it in 3 quarters since.
  • Freestone Grove Partners's Sabra Healthcare REIT position peaked at $34.9M in Q4 2025.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.